![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » HIKMA PHARMACEUTICALS SAYS PLANS LONDON IPO
HIKMA PHARMACEUTICALS SAYS PLANS LONDON IPO
Generic drug company Hikma Pharmaceuticals said on Monday it planned to float on the London Stock Exchange with a price range of 265 to 330 pence, the middle of which values it at about 500 million pounds ($874.9 million).
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct